US Stocks
/
First Tracks Biotherapeutics, Inc. Ordinary Shares Share Price
First Tracks Biotherapeutics, Inc. Ordinary Shares Share Price

First Tracks Biotherapeutics, Inc. Ordinary Shares Share Price

NASDAQ: TRAX
$36.57
+$0.46 (1.27%) Last updated on 30 Sep, 2026 | 20:02 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

First Tracks Biotherapeutics, Inc. Ordinary Shares Stock Performance

Open
$37.23
Prev. Close
$36.11
Circuit Range
N/A
Day Range
$36.14 - $37.23
Year Range
$14.98 - $49.74
Volume
3,417
Average Traded
$36.45

First Tracks Biotherapeutics, Inc. Ordinary Shares Share Price Today

As of 30 September 2026, First Tracks Biotherapeutics, Inc. Ordinary Shares's share price is $36.57. The stock opened at $37.23, compared to its previous close of $36.11. During today's trading session, First Tracks Biotherapeutics, Inc. Ordinary Shares's share price traded between $36.14 and $37.23, with an average price of $36.69. Over the past 52 weeks, the stock has recorded a high of $49.74 and a low of $14.98. In terms of performance, First Tracks Biotherapeutics, Inc. Ordinary Shares's share price has risen by 56.28% over the last six months and is up 56.28% on a year-on-year basis.

First Tracks Biotherapeutics, Inc. Ordinary Shares Share Price Chart

$36.14$37.23
L
Show Current Price
H

First Tracks Biotherapeutics, Inc. Ordinary Shares Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

First Tracks Biotherapeutics, Inc. Ordinary Shares Quarterly Profit & Loss

All figures in USD

ParticularsJun 2026
Revenue$0.00
Net Profit-$33.37
Net Profit MarginN/A
Income ChangeN/A

About First Tracks Biotherapeutics, Inc. Ordinary Shares

First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.

First Tracks Biotherapeutics, Inc. Ordinary Shares Historical Returns

MonthOpenCloseChange %
Sep 2026
$41.48
$36.64
-18.12%
Aug 2026
$44.46
$44.75
+1.50%
Jul 2026
$19.98
$44.09
+118.92%
Jun 2026
$15.87
$20.14
+26.51%
May 2026
$23.97
$15.92
-31.97%
Apr 2026
$17.00
$23.40
N/A

TRAX Share Price FAQs

What is First Tracks Biotherapeutics, Inc. Ordinary Shares share price today?

chevron-up
First Tracks Biotherapeutics, Inc. Ordinary Shares share price today is $36.57 as on September 30, 2026 at 8:02 pm IST.

What is the 52 week high and 52 week low of First Tracks Biotherapeutics, Inc. Ordinary Shares stock?

chevron-up
The 52 week high of First Tracks Biotherapeutics, Inc. Ordinary Shares stock is $49.74, while the 52 week low is $14.98 as of 30 Sep '26.

What is TRAX's net income for the last quarter?

chevron-up
TRAX's net income for the last quarter is -33.37B USD.

What is the 5 year returns of TRAX?

chevron-up
The 5 year returns of TRAX is 56.28% as on 30 Sep '26.

What is the high & low stock price of TRAX today?

chevron-up
TRAX stock price hit a high of $37.23 and low of $36.14 as of 30 Sep '26.

Can I buy TRAX shares in India?

chevron-up
Yes. You can buy TRAX in India by opening an international trading account.